The adverse effects have been resolved, the pill has been developed, the lab work done, and the first trial completed and analysed, and the application to the FDA made. Michael Thurn said the topline results would be made publuc by the end of Feb and he delivered. Under him PAA is a very tight ship.
Thankyou Dr Richard Mollard for the work that is making all this possible.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-634
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.025(13.5%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 22.0¢ | 20.0¢ | $733.4K | 3.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 113800 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 240088 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
21.0¢ |
Change
0.025 ( 13.5 %) |
||||
| Open | High | Low | Volume | ||
| 20.5¢ | 22.0¢ | 20.0¢ | 1388603 | ||
| Last updated 15.56pm 31/05/2024 ? | |||||
| PAA (ASX) Chart |